Bionaut Pharmaceuticals Inc.
This article was originally published in Start Up
Executive SummaryBionaut Pharmaceuticals is pioneering a predictive assay platform for drug discovery and lead optimization using engineered cell lines. The firm has established internal small-molecule discovery programs and partnerships in autoimmune/inflammatory diseases and cancer, and is expanding its assay capabilities into other diseases.
You may also be interested in...
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.